Nosco

Tim Matus serves as President of Nosco, leading both the manufacturing and software divisions. Nosco is a privately held operating company, not a fund manager or family office. Capital allocation decisions — such as new press acquisitions or software development initiatives — are made by company leadership and funded through operating cash flow rather than outside LP commitments.

Nosco's NoscoLink platform is a digital artwork management and proofing system that the company licenses to other packaging converters. When a pharmaceutical company contracts with a Nosco competitor that uses NoscoLink for file transfer, proofing, and approval workflows, Nosco collects a licensing fee without producing the physical carton or label. This effectively creates a royalty stream embedded across the industry.

Nosco's customer base concentrates in heavily regulated, quality-intensive sectors. The primary verticals are pharmaceuticals — including clinical-trial labeling and commercial drug packaging — medical devices, and consumer packaged goods. The company's expertise in serialization and track-and-trace requirements aligns with FDA-regulated supply chains.

Yes. Nosco operates manufacturing plants in the Midwest and Southeastern United States. Producing folding cartons, pressure-sensitive labels, and extended-content inserts near customer hubs reduces lead times for pharmaceutical launches and clinical-trial kitting operations. The firm does not disclose exact facility counts or total square footage publicly.

Nosco operates as a privately held manufacturing and software business, not a single-family office or investment firm. There is no public record of the company managing third-party capital, deploying fund vehicles, or making portfolio investments in outside businesses. Its capital goes into physical plant, equipment, and internal platform development.